BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2825862)

  • 1. [High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
    Pico JL; Baume D; Ostronoff M; Beaujean F; Gouyette A; Le Chevalier T; Arriagada R; Rebattu P; Hayat M
    Bull Cancer; 1987; 74(5):587-95. PubMed ID: 2825862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.
    Wilson C; Pickering D; Stewart S; Vallis K; Kalofonos H; Cross A; Snook D; Goldman JM; McKenzie CG; Epenetos AA
    In Vivo; 1988; 2(5):331-4. PubMed ID: 2856521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
    Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
    Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High dose chemotherapy with autologous bone marrow rescue for small cell lung cancer].
    Bao YH
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):452-5. PubMed ID: 1315671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
    Littlewood TJ; Bentley DP; Smith AP
    Eur J Respir Dis; 1986 May; 68(5):370-4. PubMed ID: 3015650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
    van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I
    Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
    Alessandrino EP; Bernasconi P; Colombo A; Caldera D; Martinelli G; Vitulo P; Malcovati L; Nascimbene C; Varettoni M; Volpini E; Klersy C; Bernasconi C
    Bone Marrow Transplant; 2000 Feb; 25(3):309-13. PubMed ID: 10673703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent issue in the treatment of small-cell lung cancer].
    Ueoka H; Hiraki S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
    Mulder NH; Meinesz AF; Sleijfer DT; Postmus PE; De Vries EG; Van der Geest S; Orie JL; Vriesendorp R
    Neth J Med; 1984; 27(10):389-92. PubMed ID: 6096742
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mega-dose chemotherapy with peripheral blood stem cell transplantation (PBS-CT) for small cell lung cancer (SCLC)].
    Chou T; Yokoyama A; Yoshizawa H; Hoshino M; Ebe T; Kurita Y; Arakawa M
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1741-8. PubMed ID: 7574804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
    Perey L; Rosti G; Lange A; Pampallona S; Bosquée L; Pasini F; Humblet Y; Hamdan O; Cetto GL; Marangolo M; Leyvraz S
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S40-3. PubMed ID: 8899170
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive therapy and autotransplantation in Hodgkin's disease.
    Reece DE; Phillips GL
    Stem Cells; 1994 Sep; 12(5):477-93. PubMed ID: 7804123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high-dose chemotherapy with autologous hematopoietic stem cell transplantation on small-cell lung cancer.
    Wang J; Zhan P; Ouyang J; Chen B; Zhou R; Yang Y
    Lung Cancer; 2009 Jul; 65(1):126-7. PubMed ID: 19394108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
    Tomeczko J; Pacuszko T; Napora P; Lange A
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease.
    Giacalone PL; Benos P; Donnadio D; Laffargue F
    Gynecol Oncol; 1995 Sep; 58(3):383-5. PubMed ID: 7672706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.